S&P 500   2,578.28 (-99.62%)
DOW   21,826.29 (+3.68%)
QQQ   189.82 (+3.52%)
AAPL   250.33 (+3.69%)
FB   160.04 (+3.80%)
MSFT   158.98 (+3.35%)
GOOGL   1,132.62 (+3.65%)
AMZN   1,936.04 (+1.54%)
CGC   13.70 (+3.40%)
BABA   193.06 (+3.18%)
MU   43.61 (+5.80%)
GE   7.02 (+4.16%)
TSLA   498.22 (+3.79%)
AMD   44.17 (+3.71%)
T   28.47 (+3.64%)
ACB   0.82 (+2.49%)
F   4.50 (+6.13%)
NFLX   365.58 (+1.05%)
BAC   21.09 (+5.24%)
GILD   78.87 (+0.84%)
DIS   96.57 (+2.87%)
PRI   85.32 (+5.74%)
S&P 500   2,578.28 (-99.62%)
DOW   21,826.29 (+3.68%)
QQQ   189.82 (+3.52%)
AAPL   250.33 (+3.69%)
FB   160.04 (+3.80%)
MSFT   158.98 (+3.35%)
GOOGL   1,132.62 (+3.65%)
AMZN   1,936.04 (+1.54%)
CGC   13.70 (+3.40%)
BABA   193.06 (+3.18%)
MU   43.61 (+5.80%)
GE   7.02 (+4.16%)
TSLA   498.22 (+3.79%)
AMD   44.17 (+3.71%)
T   28.47 (+3.64%)
ACB   0.82 (+2.49%)
F   4.50 (+6.13%)
NFLX   365.58 (+1.05%)
BAC   21.09 (+5.24%)
GILD   78.87 (+0.84%)
DIS   96.57 (+2.87%)
PRI   85.32 (+5.74%)
S&P 500   2,578.28 (-99.62%)
DOW   21,826.29 (+3.68%)
QQQ   189.82 (+3.52%)
AAPL   250.33 (+3.69%)
FB   160.04 (+3.80%)
MSFT   158.98 (+3.35%)
GOOGL   1,132.62 (+3.65%)
AMZN   1,936.04 (+1.54%)
CGC   13.70 (+3.40%)
BABA   193.06 (+3.18%)
MU   43.61 (+5.80%)
GE   7.02 (+4.16%)
TSLA   498.22 (+3.79%)
AMD   44.17 (+3.71%)
T   28.47 (+3.64%)
ACB   0.82 (+2.49%)
F   4.50 (+6.13%)
NFLX   365.58 (+1.05%)
BAC   21.09 (+5.24%)
GILD   78.87 (+0.84%)
DIS   96.57 (+2.87%)
PRI   85.32 (+5.74%)
S&P 500   2,578.28 (-99.62%)
DOW   21,826.29 (+3.68%)
QQQ   189.82 (+3.52%)
AAPL   250.33 (+3.69%)
FB   160.04 (+3.80%)
MSFT   158.98 (+3.35%)
GOOGL   1,132.62 (+3.65%)
AMZN   1,936.04 (+1.54%)
CGC   13.70 (+3.40%)
BABA   193.06 (+3.18%)
MU   43.61 (+5.80%)
GE   7.02 (+4.16%)
TSLA   498.22 (+3.79%)
AMD   44.17 (+3.71%)
T   28.47 (+3.64%)
ACB   0.82 (+2.49%)
F   4.50 (+6.13%)
NFLX   365.58 (+1.05%)
BAC   21.09 (+5.24%)
GILD   78.87 (+0.84%)
DIS   96.57 (+2.87%)
PRI   85.32 (+5.74%)
Log in

NASDAQ:CNMDCONMED Stock Price, Forecast & News

$53.53
+3.10 (+6.15 %)
(As of 04/6/2020 09:40 AM ET)
Add
Compare
Today's Range
$53.32
Now: $53.53
$54.26
50-Day Range
$39.81
MA: $80.04
$105.42
52-Week Range
$37.66
Now: $53.53
$116.81
Volume312 shs
Average Volume412,169 shs
Market Capitalization$1.53 billion
P/E Ratio56.35
Dividend Yield1.54%
Beta0.56
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. The company offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, plastic, ENT, neurological, spinal, and cardiothoracic surgeries; sports biologics and tissue products; and surgical visualization products. It offers orthopedic surgery products under Hall, CONMED Linvatec, Concept, and Shutt brands. The company also offers general surgery product in the areas of advanced surgical comprising clinical insufflation system; electrosurgical products; endomechanical products comprising instruments, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors; and VCARE uterine manipulator for enhancing the efficiency of laparoscopic hysterectomies and other gynecologic laparoscopic procedures. In addition, it offers endoscopic technologies offering, including diagnostic and therapeutic products for use in gastroenterology procedures; cardiology and critical care products cover a line of vital signs, cardiac monitoring, and patient care products, including ECG electrodes and accessories, cardiac defibrillation and pacing pads, and suction instruments and tubing; and physician's office electrosurgical product used by dermatologists. The company markets its products directly to surgeons, hospitals, surgery centers, group purchasing organizations, integrated delivery networks, and other customers, as well as through medical specialty distributors. CONMED Corporation was founded in 1970 and is headquartered in Utica, New York.
Read More
CONMED logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 2.6Dividend Strength: 3.3Insider Behavior: 3.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.59 out of 5 stars


Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:CNMD
CUSIP20741010
Phone315-797-8375

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$955.10 million
Cash Flow$2.34 per share
Book Value$23.54 per share

Profitability

Net Income$28.62 million

Miscellaneous

Employees3,100
Market Cap$1.53 billion
Next Earnings Date4/22/2020 (Estimated)
OptionableOptionable

Receive CNMD News and Ratings via Email

Sign-up to receive the latest news and ratings for CNMD and its competitors with MarketBeat's FREE daily newsletter.


CONMED (NASDAQ:CNMD) Frequently Asked Questions

How has CONMED's stock been impacted by COVID-19 (Coronavirus)?

CONMED's stock was trading at $78.77 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CNMD stock has decreased by 32.0% and is now trading at $53.53. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of CONMED?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CONMED in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for CONMED.

When is CONMED's next earnings date?

CONMED is scheduled to release its next quarterly earnings announcement on Wednesday, April 22nd 2020. View our earnings forecast for CONMED.

How were CONMED's earnings last quarter?

CONMED Co. (NASDAQ:CNMD) released its earnings results on Wednesday, January, 29th. The medical technology company reported $0.90 EPS for the quarter, beating the consensus estimate of $0.89 by $0.01. The medical technology company earned $264.90 million during the quarter, compared to the consensus estimate of $264.83 million. CONMED had a net margin of 3.00% and a return on equity of 11.18%. CONMED's quarterly revenue was up 9.3% compared to the same quarter last year. During the same quarter last year, the company posted $0.73 earnings per share. View CONMED's earnings history.

How often does CONMED pay dividends? What is the dividend yield for CONMED?

CONMED declared a quarterly dividend on Wednesday, February 26th. Investors of record on Monday, March 16th will be paid a dividend of $0.20 per share on Monday, April 6th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 1.49%. The ex-dividend date of this dividend is Friday, March 13th. View CONMED's dividend history.

What guidance has CONMED issued on next quarter's earnings?

CONMED issued an update on its FY20 earnings guidance on Wednesday, January, 29th. The company provided earnings per share (EPS) guidance of $3.08-3.13 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $3.03.

What price target have analysts set for CNMD?

5 Wall Street analysts have issued 12-month price targets for CONMED's shares. Their forecasts range from $99.00 to $136.00. On average, they expect CONMED's stock price to reach $112.50 in the next year. This suggests a possible upside of 110.2% from the stock's current price. View analysts' price targets for CONMED.

Has CONMED been receiving favorable news coverage?

News coverage about CNMD stock has trended very negative this week, according to InfoTrie. The research firm rates the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. CONMED earned a daily sentiment score of -3.3 on InfoTrie's scale. They also assigned media headlines about the medical technology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news aboutCONMED.

Are investors shorting CONMED?

CONMED saw a drop in short interest in February. As of February 28th, there was short interest totaling 781,000 shares, a drop of 9.4% from the February 13th total of 862,100 shares. Based on an average daily volume of 291,200 shares, the short-interest ratio is currently 2.7 days. Currently, 2.8% of the company's shares are short sold. View CONMED's Current Options Chain.

Who are some of CONMED's key competitors?

What other stocks do shareholders of CONMED own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CONMED investors own include AbbVie (ABBV), Bausch Health Companies (BHC), AT&T (T), Gilead Sciences (GILD), Incyte (INCY), Neurocrine Biosciences (NBIX), PRA Health Sciences (PRAH), Moody's (MCO), UnitedHealth Group (UNH) and Verizon Communications (VZ).

Who are CONMED's key executives?

CONMED's management team includes the following people:
  • Mr. Curt R. Hartman, CEO, Pres & Director (Age 55)
  • Mr. Todd W. Garner, Exec. VP & CFO (Age 50)
  • Mr. Patrick J. Beyer, Pres of CONMED International (Age 53)
  • Mr. Stanley W. Peters III, VP & GM of U.S. Advanced Surgical (Age 44)
  • Mr. Nathan Folkert, VP & GM of U.S. Orthopedics (Age 44)

What is CONMED's stock symbol?

CONMED trades on the NASDAQ under the ticker symbol "CNMD."

How do I buy shares of CONMED?

Shares of CNMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is CONMED's stock price today?

One share of CNMD stock can currently be purchased for approximately $53.53.

How big of a company is CONMED?

CONMED has a market capitalization of $1.53 billion and generates $955.10 million in revenue each year. The medical technology company earns $28.62 million in net income (profit) each year or $2.64 on an earnings per share basis. CONMED employs 3,100 workers across the globe. View additional information about CONMED.

What is CONMED's official website?

The official website for CONMED is http://www.conmed.com/.

How can I contact CONMED?

CONMED's mailing address is 525 FRENCH ROAD, UTICA NY, 13502. The medical technology company can be reached via phone at 315-797-8375.

This page was last updated on 4/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel